Medicine-Induced Acute Kidney Injury Findings from Spontaneous Reporting Systems, Sequence Symmetry Analysis and a Case–Control Study with a Focus on Medicines Used in Primary Care
Open Access
- 21 September 2022
- journal article
- research article
- Published by Springer Nature in Drug Safety
- Vol. 45 (11) , 1413-1421
Abstract
Introduction Primary care provides an opportunity to prevent community acquired, medicine or drug-induced acute kidney injury. One of the barriers to proactive prevention of medicine-induced kidney injury in primary care is the lack of a list of nephrotoxic medicines that are most problematic in primary care, particularly one that provides a comparison of risks across medicines. Objective The aim of this study was to consolidate evidence on the risks associated with medicines and acute kidney injury, with a focus on medicines used in primary care. Method We searched the MEDLINE and EMBASE databases to identify published studies of all medicines associated with acute kidney injury identified from spontaneous report data. For each medicine positively associated with acute kidney injury, as identified from spontaneous reports, we implemented a sequence symmetry analysis (SSA) and a case–control design to determine the association between the medicine and hospital admission with a primary diagnosis of acute kidney injury (representing community-acquired acute kidney injury). Administrative claims data held by the Australian Government Department of Veterans’ Affairs for the study period 2005–2019 were used. Results We identified 89 medicines suspected of causing acute kidney injury based on spontaneous report data and a reporting odds ratio above 2, from Japan, France and the US. Spironolactone had risk estimates of 3 or more based on spontaneous reports, SSA and case–control methods, while furosemide and trimethoprim with sulfamethoxazole had risk estimates of 1.5 or more. Positive association with SSA and spontaneous reports, but not case control, showed zoledronic acid had risk estimates above 2, while candesartan telmisartan, simvastatin, naproxen and ibuprofen all had risk estimates in SSA between 1.5 and 2. Positive associations with case–control and spontaneous reports, but not SSA, were found for amphotericin B, omeprazole, metformin, amlodipine, ramipril, olmesartan, ciprofloxacin, valaciclovir, mycophenolate and diclofenac. All with the exception of metformin and omeprazole had risk estimates above 2. Conclusion This research highlights a number of medicines that may contribute to acute injury; however, we had an insufficient sample to confirm associations of some medicines. Spironolactone, furosemide, and trimethoprim with sulfamethoxazole are medicines that, in particular, need to be used carefully and monitored closely in patients in the community at risk of acute kidney injury.Keywords
Funding Information
- Department of Veterans' Affairs, Australian Government
- University of South Australia
This publication has 37 references indexed in Scilit:
- Small Acute Increases in Serum Creatinine Are Associated with Decreased Long-Term Survival in the Critically IllAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Incidence, Outcomes, and Comparisons across Definitions of AKI in Hospitalized IndividualsClinical Journal of the American Society of Nephrology, 2014
- The validity of sequence symmetry analysis (SSA) for adverse drug reaction signal detectionPharmacoepidemiology and Drug Safety, 2013
- Validity of the International Classification of Diseases, Tenth Revision code for acute kidney injury in elderly patients at presentation to the emergency department and at hospital admissionBMJ Open, 2012
- Using Electronic Health Care Records for Drug Safety Signal DetectionMedical Care, 2012
- Contribution of Renal Impairment to Potentially Preventable Medication-Related Hospital AdmissionsAnnals of Pharmacotherapy, 2012
- Nocturnal Leg Cramps and Prescription Use That Precedes ThemArchives of internal medicine (1960), 2012
- Posters – Practice Development and AuditInternational Journal of Pharmacy Practice, 2011
- Small increases in serum creatinine are associated with prolonged ICU stay and increased hospital mortality in critically ill patients with cancerSupportive Care in Cancer, 2010
- Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysisPharmacoepidemiology and Drug Safety, 2009